Tesla Falls Short on Q3 Deliveries: What It Means for EV Stocks

Tesla, Inc. (TSLA) reported its third-quarter delivery numbers on October 2, falling short of what some analysts were expecting, causing the stock to drop over 6%. The EV maker delivered 462,890 vehic INO Traders Blog Alert As you requested, here are some of the latest posts from our esteemed panel of industry experts and market analysts: Tesla Falls Short on Q3 Deliveries: What It Means for EV Stocks Thursday Oct 3rd Tesla, Inc. (TSLA) reported its third-quarter delivery numbers on October 2, falling short of what some analysts were expecting, causing the stock to drop over 6%. The EV maker delivered 462,890 vehic Visit This Post Sponsor Message: 5 Top Stocks to Buy in October We recently did a deep dive analysis on the performance of all Wall Street analysts. This led us to discovering an elite group whose Buy rated picks actually beat the market by 98.4% last year. Get Their Top 5 Stocks Now > AMD and GOOGL Pull Back from Highs-Here's Why It's Time to Buy Thursday Oct 3rd The recent market volatility has created a golden opportunity for investors eyeing two tech giants: Alphabet Inc. (GOOGL) and Advanced Micro Devices, Inc. (AMD) . Both companies have seen their stock Visit This Post How China's Stimulus Could Affect Tech Stocks Globally Tuesday Oct 1st After months of sluggish economic growth and fears of missing its growth targets, China has unveiled a sweeping set of stimulus measures aimed at reviving its economy. These policies included cuts to Visit This Post Can NVDA's Share Buybacks and AI Innovation Drive the Next Rally? Friday Sep 27th NVIDIA Corporation (NVDA) has undoubtedly been one of the hottest large-cap stocks this year, surging over 150% year-to-date and more than 195% in the past 12 months. This stellar performance is drive Visit This Post Pfizer's Dividend Yield vs. Growth: Is It Time to Rebalance Your Portfolio? Friday Sep 27th Pfizer Inc. (PFE) , striving to set the standard for quality, safety, and value in the discovery, development, and manufacture of biopharmaceutical products, reported solid second-quarter 2024 earning Visit This Post Thank you! Thank you for subscribing to Blog Alerts from INO.com. You can modify your email preferences or unsubscribe here. INO.com, Inc. | 1 Pennsylvania Plaza, 39th Floor | New York, New York 10119 All trades, patterns, charts, systems, etc., discussed in this message and the product materials are for illustrative purposes only and not to be construed as specific advisory recommendations. All ideas and material presented are entirely those of the author and do not necessarily reflect those of the publisher or INO.com. Please see our user agreement. Copyright 2024 INO.com. All Rights Reserved.